Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

    January 2023 in “ DIGITAL HEALTH
    Johannes von Büren, Inga Hansen, Julian Kött, Florian Schröder, Juliana Veneroso, Stefan W. Schneider, Finn Abeck
    Image of study
    TLDR Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.
    A retrospective, cross-sectional study involving 2269 patients assessed the efficacy and safety of direct-to-consumer (DTC) teledermatology for finasteride treatment in male androgenetic alopecia (AGA). The study found that 79% of patients reported positive changes in hair appearance, and 59% reported an improvement in self-esteem. Treatment-related adverse events occurred in 12% of the patients, and full treatment adherence was reported in 87% of patients. The study concluded that DTC teledermatology may be an effective and safe treatment option for men with AGA, but treatment-related adverse events should be closely monitored. Further studies are needed to evaluate the long-term effects of the treatment.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    10 / 10 results